FDA Warning Letter: child died from overdose during clinical trial Monday, May 05, 2003 The FDA’s letter of warning to Jacqueline M. Halton, M.D. Children’s Hospital of Eastern Ontario, a participating investigator in a National Cancer Institute pediatric trial describes multiple safety violations–including massive overdoses–that led to the death of one child and serious adverse … Continue reading FDA Warning Letter: child died from overdose during clinical trial